Insider Transactions in Q2 2021 at Teladoc Health, Inc. (TDOC)
Insider Transaction List (Q2 2021)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jun 25
2021
|
Mala Murthy CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
3,851
-18.16%
|
$635,415
$165.48 P/Share
|
Jun 24
2021
|
Mala Murthy CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
7,968
+27.31%
|
-
|
Jun 15
2021
|
Adam C Vandervoort CHIEF LEGAL OFFICER, SECRETARY |
SELL
Open market or private sale
|
Direct |
558
-5.2%
|
$87,606
$157.05 P/Share
|
Jun 14
2021
|
Adam C Vandervoort CHIEF LEGAL OFFICER, SECRETARY |
BUY
Exercise of conversion of derivative security
|
Direct |
1,136
+9.58%
|
-
|
Jun 10
2021
|
Daniel Trencher CHIEF STRATEGY OFFICER |
SELL
Open market or private sale
|
Direct |
2,000
-7.85%
|
$300,000
$150.07 P/Share
|
Jun 10
2021
|
Daniel Trencher CHIEF STRATEGY OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+7.28%
|
$44,000
$22.3 P/Share
|
Jun 01
2021
|
Jason N Gorevic CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
10,000
-2.1%
|
$1,530,000
$153.34 P/Share
|
May 26
2021
|
Arnnon Geshuri CHIEF PEOPLE OFFICER |
SELL
Open market or private sale
|
Direct |
3,959
-4.08%
|
$578,014
$146.4 P/Share
|
May 25
2021
|
Sandra L Fenwick Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,176
+25.01%
|
-
|
May 25
2021
|
Karen L Daniel Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,175
+16.83%
|
-
|
May 25
2021
|
Christopher Bischoff |
BUY
Exercise of conversion of derivative security
|
Direct |
715
+12.25%
|
-
|
May 14
2021
|
David L Shedlarz Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,049
+17.4%
|
-
|
May 14
2021
|
David B Snow Jr Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,049
+2.12%
|
-
|
May 14
2021
|
Thomas Mckinley Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,049
+15.14%
|
-
|
May 14
2021
|
Mark Douglas Smith Director |
BUY
Exercise of conversion of derivative security
|
Direct |
524
+12.91%
|
-
|
May 10
2021
|
Daniel Trencher CHIEF STRATEGY OFFICER |
SELL
Open market or private sale
|
Direct |
2,000
-7.85%
|
$300,000
$150.0 P/Share
|
May 10
2021
|
Daniel Trencher CHIEF STRATEGY OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,812
+6.64%
|
$39,864
$22.3 P/Share
|
May 07
2021
|
David B Snow Jr Director |
BUY
Bona fide gift
|
Indirect |
52,000
+50.0%
|
-
|
May 07
2021
|
David B Snow Jr Director |
SELL
Bona fide gift
|
Direct |
52,000
-52.35%
|
-
|
May 04
2021
|
Jason N Gorevic CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
10,000
-0.3%
|
$1,570,000
$157.24 P/Share
|
Apr 19
2021
|
Hemant Taneja Director |
SELL
Open market or private sale
|
Direct |
25,000
-1.88%
|
$4,650,000
$186.25 P/Share
|
Apr 14
2021
|
Daniel Trencher CHIEF STRATEGY OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
9,167
+11.89%
|
$220,008
$24.35 P/Share
|
Apr 12
2021
|
Daniel Trencher CHIEF STRATEGY OFFICER |
SELL
Open market or private sale
|
Direct |
2,000
-12.12%
|
$362,000
$181.0 P/Share
|
Apr 12
2021
|
Daniel Trencher CHIEF STRATEGY OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+10.81%
|
$44,000
$22.3 P/Share
|
Apr 06
2021
|
Jason N Gorevic CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
25,000
-1.0%
|
$4,550,000
$182.53 P/Share
|
Apr 01
2021
|
Glen Tullman Director |
SELL
Open market or private sale
|
Direct |
329,863
-10.39%
|
$61,024,655
$185.75 P/Share
|
Apr 01
2021
|
Glen Tullman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
329,863
+35.26%
|
$1,649,315
$5.26 P/Share
|